Filing Flows › LifeStance Health Group (LFST) › Capital expenditures
LifeStance Health Group (LFST) capital expenditures by quarter
LifeStance Health Group's capital expenditures were $14.7M in Q3 2026 (third quarter 2026), +22% from Q2 2026. Over the last 6 quarters it ranged from $7.8M (Q2 2025) to $14.7M (Q3 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $14.7M | +22% | +42% |
| Q2 2026 | $12.0M | +11% | +55% |
| Q1 2026 | $10.8M | -1% | — |
| Q4 2025 | $10.9M | +6% | — |
| Q3 2025 | $10.3M | +33% | — |
| Q2 2025 | $7.8M | — | — |
Q3 2026 at a glance
LifeStance Health Group, Q3 2026: revenue $456M (+25% year over year), operating margin 7.3%, net earnings $22.4M, operating cash flow $37.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is LifeStance Health Group's capital expenditures?
LifeStance Health Group's capital expenditures were $14.7M in Q3 2026 (third quarter 2026), +22% from Q2 2026.
How has LifeStance Health Group's capital expenditures changed?
Over the last 6 quarters it ranged from $7.8M (Q2 2025) to $14.7M (Q3 2026).
Q3 2026 results → · How LifeStance Health Group makes money →